Northern Devon Healthcare NHS Trust > policy > pharmacy > Protocol for the Administration of Intravenous Zoledronic Acid for the Management of Osteoporosis and Paget’s Disease

Protocol for the Administration of Intravenous Zoledronic Acid for the Management of Osteoporosis and Paget’s Disease

Posted on January 9, 2017January 9, 2017

Protocol for the Administration of Intravenous Zoledronic Acid for the Management of Osteoporosis and Paget’s Disease

Posted in pharmacy, policy, rheumatology and tagged Zoledronic Acid IV Protocol.

Last updated: January 9, 2017

Font Resize